Euroconference on tissue repair and ulcer/wound healing: molecular mechanisms, therapeutic targets and future directions.
The meeting was part of the Euroconference series organised at the Pasteur Institute in Paris. Comprising delegates from both academia and industry, it drew on expertise from many aspects of tissue repair in a wide range of human disease. The principal component of this report concerns progress with the therapeutic application of biological agents in promoting tissue repair, as gene therapeutics, monoclonal antibodies and therapeutic proteins. In addition, the effect of pioglitazone on the rate and quality of wound healing in diabetic rats is also reported.
Braddock
Martin
M
Discovery Bioscience, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK. martin.braddock@astrazeneca.com
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D016503:Drug Delivery Systems / Q000379:methods / Q000639:trends*; D015507:Drugs, Investigational / Q000008:administration & dosage*; D005060:Europe; D015316:Genetic Therapy / Q000379:methods / Q000639:trends; D006801:Humans; D010297:Paris; D012038:Regeneration / Q000187:drug effects / Q000502:physiology; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000235:genetics; D014945:Wound Healing / Q000187:drug effects* / Q000235:genetics
D000911:Antibodies, Monoclonal; D015507:Drugs, Investigational